2.3.1.59
acetyl-CoA + butirosin
acetylated at 30% the rate of gentamicin C1
487273
Providencia sp.
CoA + ?
?
2.3.1.59
acetyl-CoA + dideoxykanamycin
acetylated at 92% the rate of gentamicin C1
487273
Providencia sp.
CoA + N2'-diacetyldideoxykanamycin
?
2.3.1.59
acetyl-CoA + gentamicin B
7% of the activity with gentamicin C1
487273
Providencia sp.
CoA + N2'-acetylgentamycin
?
2.3.1.59
acetyl-CoA + gentamicin C1
best substrate
487273
Providencia sp.
CoA + N2'-acetylgentamicin C1
?
2.3.1.59
acetyl-CoA + gentamicin C1
best substrate
487273
Providencia sp. 164
CoA + N2'-acetylgentamicin C1
?
2.3.1.59
acetyl-CoA + gentamicin C1a
acetylated at 86% the rate of gentamicin C1
487273
Providencia sp.
CoA + N2'-acetylgentamicin C1a
?
2.3.1.59
acetyl-CoA + gentamicin C1a
acetylated at 86% the rate of gentamicin C1
487273
Providencia sp. 164
CoA + N2'-acetylgentamicin C1a
?
2.3.1.59
acetyl-CoA + kanamycin B
acetylated at 14% the rate of gentamicin C1
487273
Providencia sp.
CoA + N2-acetylkanamycin B
?
2.3.1.59
acetyl-CoA + kanamycin C
acetylated at 40% the rate of gentamicin C1
487273
Providencia sp.
CoA + N2'-acetylkanamycin C
?
2.3.1.59
acetyl-CoA + neomycin B
acetylated at 10% the rate of gentamicin C1
487273
Providencia sp.
CoA + N2'-acetylneomycin
?
2.3.1.59
acetyl-CoA + ribostamycin
acetylated at 15% the rate of gentamicin C1
487273
Providencia sp.
CoA + N2'-acetylribostamycin
?
2.3.1.59
acetyl-CoA + sisomicin
acetylated at 71% the rate of gentamicin C1
487273
Providencia sp.
CoA + N3'-acetylsisomicin
2.3.1.59
acetyl-CoA + sisomicin
acetylated at 71% the rate of gentamicin C1
487273
Providencia sp. 164
CoA + N3'-acetylsisomicin
2.3.1.59
acetyl-CoA + tobramycin
acetylated at 58% the rate of gentamicin C1
487273
Providencia sp.
CoA + N2'-acetyltobramycin
?
2.3.1.59
acetyl-CoA + tobramycin
acetylated at 58% the rate of gentamicin C1
487273
Providencia sp. 164
CoA + N2'-acetyltobramycin
?
2.3.1.59
acetyl-CoA of soluble fragments of peptidoglycan + tobramycin
acetylated at 58% the rate of gentamicin C1
487273
Providencia sp.
?
?
2.3.1.59
additional information
no substrates are kanamycin A and 1-hydroxyaminobutyric acid kanamycin A-derivative BB-K 8
487273
Providencia sp.
?
2.3.1.59
additional information
no substrates are kanamycin A and 1-hydroxyaminobutyric acid kanamycin A-derivative BB-K 8
487273
Providencia sp. 164
?
2.3.1.59
N-acetyl-D-glucosamine + tobramycin
acetylated at 58% the rate of gentamicin C1
487273
Providencia sp.
D-glucosamine + N2'-acetyltobramycin
?
2.3.1.59
acetyl-CoA + butirosin
acetylated at 30% the rate of gentamicin C1
487273
Providencia sp.
CoA + ?
?
2.3.1.59
acetyl-CoA + dideoxykanamycin
acetylated at 92% the rate of gentamicin C1
487273
Providencia sp.
CoA + N2'-diacetyldideoxykanamycin
?
2.3.1.59
acetyl-CoA + gentamicin B
7% of the activity with gentamicin C1
487273
Providencia sp.
CoA + N2'-acetylgentamycin
?
2.3.1.59
acetyl-CoA + gentamicin C1
best substrate
487273
Providencia sp.
CoA + N2'-acetylgentamicin C1
?
2.3.1.59
acetyl-CoA + gentamicin C1
best substrate
487273
Providencia sp. 164
CoA + N2'-acetylgentamicin C1
?
2.3.1.59
acetyl-CoA + gentamicin C1a
acetylated at 86% the rate of gentamicin C1
487273
Providencia sp.
CoA + N2'-acetylgentamicin C1a
?
2.3.1.59
acetyl-CoA + gentamicin C1a
acetylated at 86% the rate of gentamicin C1
487273
Providencia sp. 164
CoA + N2'-acetylgentamicin C1a
?
2.3.1.59
acetyl-CoA + kanamycin B
acetylated at 14% the rate of gentamicin C1
487273
Providencia sp.
CoA + N2-acetylkanamycin B
?
2.3.1.59
acetyl-CoA + kanamycin C
acetylated at 40% the rate of gentamicin C1
487273
Providencia sp.
CoA + N2'-acetylkanamycin C
?
2.3.1.59
acetyl-CoA + neomycin B
acetylated at 10% the rate of gentamicin C1
487273
Providencia sp.
CoA + N2'-acetylneomycin
?
2.3.1.59
acetyl-CoA + ribostamycin
acetylated at 15% the rate of gentamicin C1
487273
Providencia sp.
CoA + N2'-acetylribostamycin
?
2.3.1.59
acetyl-CoA + sisomicin
acetylated at 71% the rate of gentamicin C1
487273
Providencia sp.
CoA + N3'-acetylsisomicin
2.3.1.59
acetyl-CoA + sisomicin
acetylated at 71% the rate of gentamicin C1
487273
Providencia sp. 164
CoA + N3'-acetylsisomicin
2.3.1.59
acetyl-CoA + tobramycin
acetylated at 58% the rate of gentamicin C1
487273
Providencia sp.
CoA + N2'-acetyltobramycin
?
2.3.1.59
acetyl-CoA + tobramycin
acetylated at 58% the rate of gentamicin C1
487273
Providencia sp. 164
CoA + N2'-acetyltobramycin
?
2.3.1.59
acetyl-CoA of soluble fragments of peptidoglycan + tobramycin
acetylated at 58% the rate of gentamicin C1
487273
Providencia sp.
?
?
2.3.1.59
additional information
no substrates are kanamycin A and 1-hydroxyaminobutyric acid kanamycin A-derivative BB-K 8
487273
Providencia sp.
?
2.3.1.59
additional information
no substrates are kanamycin A and 1-hydroxyaminobutyric acid kanamycin A-derivative BB-K 8
487273
Providencia sp. 164
?
2.3.1.59
N-acetyl-D-glucosamine + tobramycin
acetylated at 58% the rate of gentamicin C1
487273
Providencia sp.
D-glucosamine + N2'-acetyltobramycin
?